Workshop F: Supercharging Development of Innovative Platforms for Identification & Validation of Novel Targets Beyond CD19

Time: 3:00 pm
day: Workshop – Track B – Evening


  • Identifying novel targets with potential to develop next generation CAR-TCR therapies with reduced toxic effects of on-target off-tumour reactivity
  • Innovative preclinical and clinical trial designs to maximise patient success
  • Exploring new ways to model tumour burden to gain a realistic representation of translation in humans
  • Validating preclinical models and interpreting data from these models correctly